Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,470.00    50.00 (2.07%)
Bid:
2,466.00
Ask:
2,470.00
Spread: 4.00 (0.162%)
Market Cap: £7.93b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Acquisition

23 Nov 2017 07:00

RNS Number : 2712X
Bunzl PLC
23 November 2017
 

23 November 2017

 

 

BUNZL COMPLETES ACQUISTION IN FRANCE AND ANNOUNCES FURTHER EXPANSION IN AUSTRALIA AND BRAZIL

 

Bunzl plc, the international distribution and outsourcing Group, today announces that the acquisition of Hedis, Comptoir de Bretagne and Générale Collectivités, that was announced on 20 July 2017, has been completed following clearance of the transaction by the French Competition Authority.

 

The Company has also recently acquired Interpath in Australia and entered into an agreement to acquire Talge in Brazil.

 

Interpath, which is based in Melbourne, is principally engaged in the distribution of a variety of laboratory and healthcare related consumable products to the pathology, medical research and life science end user markets in Australia. Customers include public and private hospitals and other pathology and research laboratories. Revenue in the year ended June 2017 was A$22 million (c.£13 million).

 

Talge, which is based in Santa Catarina, is principally engaged in the sale of a variety of foodservice related products, mainly to redistributors in the southeast region of Brazil. Revenue in the year ended December 2016 was R$83 million (c.£20 million). Completion of the acquisition is subject to clearance of the transaction by the Brazilian competition authority.

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive of Bunzl said:

 

"I am delighted that we have now completed the purchase of Hedis, Comptoir de Bretagne and Générale Collectivités. Together these businesses further expand our existing cleaning & hygiene operations in France and extend our business there into the catering equipment sector for the first time.

 

The acquisition of Interpath has enhanced our healthcare business in Australia and extended our product offering into the pathology, medical research and life science markets there, while the proposed purchase of Talge will expand our operations into the foodservice sector in Brazil."

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: 020 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: 020 7353 4200

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBTBATMBTTBTR
Date   Source Headline
29th Oct 20207:00 amRNSIssue of Debt
27th Oct 20205:13 pmRNSDirector/PDMR Shareholding
20th Oct 20209:30 amRNSDirector/PDMR Shareholding
15th Oct 20205:43 pmRNSDirector/PDMR Shareholding
15th Oct 20205:41 pmRNSDirector/PDMR Shareholding
15th Oct 20205:37 pmRNSDirector/PDMR Shareholding
14th Oct 20207:00 amRNSTrading Statement
7th Oct 202012:30 pmRNSDirector/PDMR Shareholding
5th Oct 20205:25 pmRNSDirector/PDMR Shareholding
1st Oct 20201:15 pmRNSDirector/PDMR Shareholding
1st Oct 202012:45 pmRNSTotal Voting Rights
9th Sep 20205:25 pmRNSDirector/PDMR Shareholding
3rd Sep 20204:25 pmRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSAcquisition
1st Sep 20209:30 amRNSTotal Voting Rights
27th Aug 20204:12 pmRNSDirector/PDMR Shareholding
25th Aug 20205:15 pmRNSDirector/PDMR Shareholding
24th Aug 20205:15 pmRNSDirector/PDMR Shareholding
24th Aug 20205:15 pmRNSDirector/PDMR Shareholding
24th Aug 202010:00 amRNSDividend Declaration
24th Aug 20207:00 amRNSHalf-year Report
24th Aug 20207:00 amRNSAcquisition
5th Aug 20203:12 pmRNSDirector/PDMR Shareholding
3rd Aug 202010:19 amRNSTotal Voting Rights
21st Jul 20209:00 amRNSPublication of Admission Particulars
3rd Jul 20201:04 pmRNSDirector/PDMR Shareholding
1st Jul 202011:00 amRNSTotal Voting Rights
30th Jun 20203:16 pmRNSHolding(s) in Company
30th Jun 202011:20 amRNSDirector/PDMR Shareholding
29th Jun 20205:15 pmRNSDirector/PDMR Shareholding
26th Jun 20203:40 pmRNSHolding(s) in Company
15th Jun 20207:00 amRNSTrading Statement
3rd Jun 202012:40 pmRNSDirector/PDMR Shareholding
1st Jun 202010:35 amRNSTotal Voting Rights
4th May 20205:29 pmRNSDirector/PDMR Shareholding
1st May 20201:55 pmRNSDirector/PDMR Shareholding
1st May 202012:30 pmRNSTotal Voting Rights
1st May 20209:00 amRNSBlock listing Interim Review
27th Apr 202012:00 pmRNSDisclosure of rights attached to equity shares
23rd Apr 20204:24 pmRNSHolding(s) in Company
22nd Apr 20207:00 amRNSDirectorate Change
20th Apr 20203:51 pmRNSHolding(s) in Company
15th Apr 20202:07 pmRNSResult of AGM
14th Apr 20204:55 pmRNSDirector/PDMR Shareholding
7th Apr 20209:25 amRNSDirector/PDMR Shareholding
6th Apr 20203:00 pmRNS2020 AGM update
3rd Apr 202011:15 amRNSDirector/PDMR Shareholding
2nd Apr 20207:00 amRNSTrading Statement
1st Apr 202010:20 amRNSTotal Voting Rights
30th Mar 20204:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.